Arcosa Inc
Construction
Arcosa Inc (ACA) Stock News
The latest ACA headlines and market coverage — 5 recent stories, updated throughout the day.
- Zacks Investment Research·
Can Oscar Health Turn ACA Marketplace Growth Into Lasting Profits?
Oscar Health (OSCR) has surged 130% year-to-date driven by ACA marketplace expansion and plans to enter 150+ metro areas by 2027. However, the stock trades at a premium 4.94 price-to-book ratio versus the industry average of 2.64, and long-term profitability depends on disciplined underwriting and cost management rather than favorable policy conditions alone. Concentration risk from ACA exposure and potential subsidy policy changes pose headwinds.
- GlobeNewswire Inc.·
Cytokinetics Announces Additional Results from ACACIA-HCM and MAPLE-HCM Presented in Late Breaking Clinical Trial Session at the European Society of Cardiology (ESC) Congress 2026
Cytokinetics presented additional clinical trial results for aficamten (MYQORZO) at the ESC Congress 2026. ACACIA-HCM data showed aficamten improved cardiac structure and diastolic function in non-obstructive HCM patients beyond exercise capacity improvements. MAPLE-HCM analysis demonstrated aficamten outperformed metoprolol across different pre-trial treatment groups in obstructive HCM patients. The company plans to submit a Supplemental New Drug Application for non-obstructive HCM in Q4 2026.
- GlobeNewswire Inc.·
Halper Sadeh LLC is Investigating Whether BZH, ACA, SYNA, CRNX are Obtaining Fair Deals for their Shareholders
Halper Sadeh LLC, an investor rights law firm, is investigating four companies for potential securities law violations and breaches of fiduciary duties related to their proposed acquisitions. The firm is examining whether shareholders are receiving fair consideration and whether insider benefits may be limiting superior competing offers. The investigations cover Beazer Homes' sale to Dream Finders Homes, Arcosa's sale to CRH, Synaptics' sale to onsemi, and Crinetics Pharmaceuticals' sale to Vertex Pharmaceuticals.
- GlobeNewswire Inc.·
Halper Sadeh LLC is Investigating Whether ACA, TECH, IRDM, LCII are Obtaining Fair Deals for their Shareholders
Halper Sadeh LLC, an investor rights law firm, is investigating four companies for potential violations of federal securities laws and breaches of fiduciary duties related to their proposed acquisitions. The firm is examining whether shareholders are receiving fair consideration and whether insider benefits may be limiting superior competing offers.
- GlobeNewswire Inc.·
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Arcosa, Inc. (NYSE – ACA), Fathom Holdings Inc. (Nasdaq – FTHM), Nuvalent, Inc. (Nasdaq – NUVL), Dana Incorporated (NYSE – DAN)
Law firm Brodsky & Smith announced investigations into four major merger transactions, examining whether company boards breached fiduciary duties by failing to conduct fair processes and provide fair value to shareholders. The investigations involve Arcosa (CRH acquisition for $150/share), Fathom Holdings (Bed Bath & Beyond acquisition), Nuvalent (GSK acquisition for $124/share), and Dana Incorporated (Eaton Corporation acquisition).